Trial Profile
Effects of sitagliptin on on BNP, NT-proBNP, cGMP, aldosterone and LVMI in patients with type 2 diabetes and stable chronic heart failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2011
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Chronic heart failure; Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 07 Sep 2011 New trial record
- 31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.